Breast Cancer

Having higher cardiorespiratory fitness may be a protective factor against breast cancer for postmenopausal women with elevated body fat, according to the results of research published in the British Journal of Sports Medicine.

Treatment with anthracyclines for breast cancer or lymphoma correlated with more than two times higher risk for congestive heart failure than that of healthy controls, according to a study conducted at Mayo Clinic.

So far in 2023, there has been an overwhelming shortage of chemotherapy drugs, of which several specifically impact gynecologic oncology providers and patients.

Sara A. Hurvitz, MD, has been appointed senior vice president of the clinical research division at Fred Hutchinson Cancer Center.

High allostatic load appeared associated with increased risk for all-cause mortality among patients with breast cancer, according to study results published in JAMA Network Open.

The V Foundation has awarded Debattama Sen, PhD, a $200,000 grant to explore strategies to regulate T-cell dysfunction in chronic viral infection and tumors in patients with cancer.

FDA announced the creation of a voluntary pilot program that will assist clinicians in selecting the appropriate treatment for patients with cancer through the use of laboratory-developed tests, according to an FDA press release.

CHICAGO — An electronic frailty index may help to predict risk for poor outcomes, including mortality, in patients undergoing chemotherapy.

The number of cancer survivors diagnosed with a new malignancy increased by 15% from 2013 to 2019, according to data published in JAMA Oncology.

CHICAGO — A novel clinical decision support tool appeared effective at promoting cardiovascular health discussions during routine follow-up care for cancer survivors, according to study results presented at ASCO Annual Meeting.